415P Patterns of time-to-progression intervals across clinical and liquid biopsy (LB) features in hormone receptor-positive (HR+) HER2-negative (HER2-) metastatic breast cancer (MBC) patients (pts) treated with first-line endocrine therapy (ET)

Autor: Cucciniello, L., Noto, C., Bolzonello, S., Molteni, E., Da Ros, L., Pastò, B., Franzoni, A., Spazzapan, S., Russo, S., Foffano, L., Buriolla, S., Targato, G., Allegri, L., Dri, A., Della Rossa, S., Bonotto, M., Damante, G., Belletti, B., Gerratana, L., Puglisi, F.
Zdroj: In Annals of Oncology October 2023 34 Supplement 2:S357-S357
Databáze: ScienceDirect